(Q72586945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Low-dose aminoglutethimide in treatment of advanced breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

aminoglutethimide hydrochloride

27 October 2019

main subject

0 references

author name string

R. Stuart-Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

M. Dowsett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

T. Bozek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

J. A. McKinna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

J. C. Gazet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

S. L. Jeffcoate

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

A. Kurkure

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

L. Carr

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

I. E. Smith

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147642

14 August 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

15 September 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6147642

full work available at URL

14 August 2023

https://api.elsevier.com/content/article/PII:S0140673684905968?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90596-8

https://api.elsevier.com/content/article/PII:S0140673684905968?httpAccept=text/plain

14 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90596-8

14 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

604-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

Aminoglutethimide in treatment of metastatic breast carcinoma

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Inhibition studies on the aromatization of androst-4-ene-3,17-dione by human placental microsomal preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Plasma Precursors of Estrogen. I. Extent of Conversion of Plasma Δ4-Androstenedione to Estrone in Normal Males and Nonpregnant Normal, Castrate and Adrenalectomized Females

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Source of Estrogen Production in Postmenopausal Women1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Aminoglutethimide dose and hormone suppression in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

A dose response evaluation of delta-1-testololactone in advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990596-8

7 January 2021

Aminoglutethimide in the treatment of advanced postmenopausal breast cancer

6

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90596-8

Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma

14 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90596-8

14 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147642%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference